The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in
Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a …

Lack of evidence on SARS-CoV-2 transmission dynamics has led to shifting isolation
guidelines between airborne and droplet isolation precautions. During the initial isolation of 13 …

Background In March 2014, the World Health Organization was notified of an outbreak of
Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, …

Background Aerosol transmission of COVID-19 is the subject of ongoing policy debate.
Characterizing aerosol produced by people with COVID-19 is critical to understanding the role of …

Background Leptospirosis has a wide‐ranging clinical and public health impact. Leptospira
are globally distributed. Case attack rates are as high as 1: 4 to 2: 5 persons in exposed …

In the light of the urgency raised by the COVID-19 pandemic, global investment in wildlife
virology is likely to increase, and new surveillance programmes will identify hundreds of novel …

The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly
increased accumulation of human genotypic, phenotypic and clinical data, and improved our …

The 2013–16 Ebola virus disease outbreak in west Africa was associated with unprecedented
challenges in the provision of care to patients with Ebola virus disease, including absence …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission causing
coronavirus disease 2019 (COVID-19) may occur through multiple routes. We collected aerosol …

Background Leptospira infection is a global zoonosis with significant health impact for
agricultural workers and those persons whose work or recreation takes them into endemic areas. …